Sigyn Therapeutics, Inc. ("Sigyn" or the "Company") (OTCQB: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. Dear Readers, Aside from ongoing COVID infections and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback